0.280
0.13 (85.43%)
| Penutupan Terdahulu | 0.151 |
| Buka | 0.151 |
| Jumlah Dagangan | 23,778 |
| Purata Dagangan (3B) | 3,218 |
| Modal Pasaran | 583,100,736 |
| Harga / Pendapatan (P/E Ke hadapan) | 6.73 |
| Harga / Jualan (P/S) | 4.63 |
| Harga / Buku (P/B) | 4.31 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 28 Aug 2025 |
| Margin Operasi (TTM) | -57,123.49% |
| EPS Cair (TTM) | -2.25 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -26.20% |
| Nisbah Semasa (MRQ) | 1.57 |
| Aliran Tunai Operasi (OCF TTM) | -157.81 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -79.30 M |
| Pulangan Atas Aset (ROA TTM) | -73.34% |
| Pulangan Atas Ekuiti (ROE TTM) | -3,383.08% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Opthea Limited | Bercampur | Bercampur |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 3.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 0.0 |
| Penilaian Relatif | NA |
| Kesihatan Kewangan | -3.2 |
| Persekitaran Makro | -1.3 |
| AI Insight | NA |
| AI Technical | NA |
| Purata | 0.02 |
|
Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. The company geographically operates Australia and United States. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Institusi | 5.06% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |